The global pharmaceutical industry is witnessing a significant shift toward sterile injectable therapies, driven by the increasing prevalence of chronic diseases, critical care treatments, hospital-based therapies, biologics, and complex drug delivery systems. Injectable formulations continue to be among the fastest-growing segments of the pharmaceutical market, owing to their rapid onset of action, superior bioavailability, and critical role in emergency and specialty care.
Located in SIDCUL, Kotdwar, Uttarakhand, Plant X is a dedicated sterile manufacturing facility specializing in injectable dosage forms and β-Lactam products. Equipped with advanced manufacturing infrastructure, validated aseptic processes, and comprehensive quality systems, the facility enables pharmaceutical companies to confidently develop, manufacture, and commercialize high-quality injectable medicines for domestic and international markets.
Injectable Dosage Forms
Dedicated Manufacturing
SIDCUL, Uttarakhand
India has emerged as one of the world's most preferred pharmaceutical manufacturing destinations, positioning Akums to help partners capitalize on growing opportunities while maintaining high standards of quality and compliance.
Projected by the early 2030s, driven by oncology, anti-infectives, critical care, vaccines, and biologics.
The global CDMO market continues to expand as companies outsource for flexibility, cost, and speed to market.
Backed by a strong scientific talent pool and globally compliant, competitive manufacturing infrastructure.
Manufacturing sterile injectable medicines requires one of the most controlled production environments in the pharmaceutical industry. Plant X integrates advanced sterile manufacturing technologies with robust environmental monitoring, validated processes, and comprehensive quality assurance protocols — guided by current Good Manufacturing Practices (cGMP), scientific risk management, and continuous quality monitoring from technology transfer through commercial production.
Dedicated production areas and controlled manufacturing environments help minimize cross-contamination risks while maintaining the highest levels of product quality and operational efficiency.
Sterile dry powder injection manufacturing for reconstitutable formulations.
Aseptic manufacturing of sterile injectable dosage forms.
Manufactured within a Low Relative Humidity Facility.
Dedicated dry syrup manufacturing for Penam formulations.
Dedicated β-Lactam dry powder injection manufacturing.
As part of Akums' integrated CDMO ecosystem, Plant X supports customers throughout the product lifecycle, enabling pharmaceutical companies to reduce time-to-market while maintaining confidence in product quality and supply continuity.
Comprehensive quality systems ensure consistent batch reproducibility, data integrity, traceability, and regulatory compliance throughout the manufacturing lifecycle.
Whether supporting established brands or new product introductions, Plant X is equipped to deliver reliable manufacturing solutions across the product lifecycle.
Purpose-built infrastructure designed to maintain the highest standards of sterility, process control, and product quality.
Backed by Akums' end-to-end development and manufacturing ecosystem, enabling seamless progression to commercial-scale manufacturing.
Comprehensive quality systems, validated processes, and continuous monitoring designed to ensure consistency, compliance, and patient safety.
Flexible manufacturing capabilities that support diverse product portfolios, changing market requirements, and varying production volumes.
Cross-functional technical, manufacturing, and quality teams working closely with customers to ensure efficient execution and long-term partnership.
Comprehensive documentation, quality records, and regulatory support designed to facilitate product approvals, audits, and successful market commercialization.
Akums Manufacturing Unit 10 reflects this commitment—combining advanced sterile manufacturing capabilities with deep pharmaceutical expertise to support the development and commercialization of therapies that improve patient outcomes. By enabling reliable, high-quality injectable manufacturing, Plant X continues to strengthen Akums' position as one of India's leading Contract Development and Manufacturing Organizations, empowering healthcare companies to bring essential medicines to patients faster, safer, and more efficiently.
Akums Healthcare Limited – Plant X
Plot No. B-6, 7, 8 & 9,
Sector-I, Siggadi Growth Centre, SIDCUL,
Kotdwar, District Pauri Garhwal – 246149, Uttarakhand, India
Partner with Akums Manufacturing Unit 10 (Plant X) for sterile injectable and β-Lactam manufacturing built for regulatory excellence, scalability, and speed to market.
Partner with Akums to elevate your pharmaceutical, nutraceutical, and cosmetic supply chain. As India's leading CDMO, we offer end-to-end solutions, including R&D, formulation development, and large-scale manufacturing. Our state-of-the-art facilities comply with stringent global standards, ensuring product safety, efficacy, and quality. With a strong focus on innovation, we deliver tailored solutions to meet your unique business needs. Whether you're launching a new product or enhancing your current supply chain, Akums provides reliable expertise, seamless scalability, and unwavering commitment to excellence. Join hands with Akums to strengthen your brand and achieve sustained growth in competitive markets.